Skip to content

The Clinical Study on the Effects of Dao Yin on Cardiopulmonary Function in Ovarian Cancer Patients

A Clinical Study on the Impact of Dao Yin on Cardiopulmonary Function in Ovarian Cancer Patients Based on the Theory of "Qi and Blood"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000098
Enrollment
Unknown
Registered
2024-06-13
Start date
2024-06-30
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Interventions

Control group 2:Brisk walking
Control group 1:No intervention measures are taken.

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meets the above diagnostic criteria; (2) Normal levels of tumor markers such as CA125, CA199, CEA, HE4, etc., and patients are currently in a progression-free survival period; (3) Borg dyspnea score between 11 and 15; (4) Age between 45 and 70; (5) Willing to participate and sign the informed consent form either by themselves or through a legal guardian.

Exclusion criteria

Exclusion criteria: (1) Patients with contraindications to exercise rehabilitation; (2) Patients with severe chronic obstructive pulmonary disease (COPD) classified as Grade II-IV according to the Chinese Medical Association's "Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease"; (3) Ovarian cancer is not the primary tumor and is combined with an untreated secondary malignant tumor; (4) Patients with stage III-V chronic kidney disease; (5) Patients with mobility difficulties such as bone metastasis, fractures, severe joint deformities, etc., which prevent the completion of the exercise therapy plan; (6) Berg Balance Scale score less than 40; (7) Montreal Cognitive Assessment (MoCA) score less than 27.

Design outcomes

Primary

MeasureTime frame
Six-Minute Walk Test Distance;

Secondary

MeasureTime frame
Safety index;quality of life;Physical balance function;Tumor marker levels; sleep quality;

Countries

China

Contacts

Public ContactTianyang Tan

Xiyuan Hospital, China Academy of Chinese Medical Sciences

390985355@qq.com18513726662

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026